Balyasny Asset Management’s Faeth Therapeutics, Inc. Common Stock FTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$511K Buy
2021
Q2
Sell
2021
Q1
$401K Buy